JFG
LFCR icon

Jefferies Financial Group’s Lifecore Biomedical LFCR Stock Holding History

Jefferies Financial Group’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-32,500
Closed -$121K – 1870
2026
Q1 		$121K Buy
+32,500
New +$224K ﹤0.01% 1583
2024
Q2 		– Sell
-18,700
Closed -$99.3K – 1661
2024
Q1 		$99.3K Buy
18,700
+1,000
+6% +$7.15K ﹤0.01% 1440
2023
Q4 		$110K Hold
17,700
– – ﹤0.01% 1538
2023
Q3 		$134K Buy
+17,700
New +$162K ﹤0.01% 1410

Other funds holding LFCR

WC
Wynnefield Capital New York $145M AUM 14.57% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $40.6M AUM 156.55% 1-Year Est. Return
GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $154M AUM 15.9% 1-Year Est. Return
3C
325 Capital New York $419M AUM 75.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $2.16B AUM 28.56% 1-Year Est. Return

Jefferies Financial Group's LFCR Position: Q2 2026 in Review

Jefferies Financial Group sold out of Lifecore Biomedical (LFCR) in Q2 2026, closing a stake of 32,500 shares — an estimated $121K sold.

Jefferies Financial Group first reported a position in LFCR in Q3 2023 and held it in 4 quarters. The position peaked at $134K in Q3 2023. 98 funds tracked by Wall St. Rank hold LFCR as of Q2 2026.

  • Jefferies Financial Group reported no remaining Lifecore Biomedical position as of Q2 2026 after selling out during the quarter.
  • Jefferies Financial Group sold 32,500 Lifecore Biomedical shares in Q2 2026, an estimated $121K.
  • Jefferies Financial Group first reported a position in Lifecore Biomedical in Q3 2023 and held it in 4 quarters.
  • Jefferies Financial Group's Lifecore Biomedical position peaked at $134K in Q3 2023.
  • 98 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.